Management Team

Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company's development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett's diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

Doreen McMorran serves as the Vice President of Business Development at Skinvisible Pharmaceuticals, Inc. In this role, working in conjunction with the company’s research and development department, she spearheads the company's research-driven product development strategies and technology/product out-licensing initiatives. Ms. McMorran brings over 25 years of experience in the medical and pharmaceutical sectors to her roles. Before joining Skinvisible Pharmaceuticals, Inc., Ms. McMorran spent six years marketing and selling to international dermatology and skincare companies. She also provided medical education, both traditional and online, for physicians and consumers. Her career includes six years in the pharmaceutical industry, as well as senior management positions at various healthcare companies, where she focused on business development, new product development, sales, marketing, and operations. She holds a Bachelor of Commerce degree with Honors.

James A. Roszell obtained his Ph.D. in chemistry from The University of Memphis. He has over 35 years of experience in product formulation, experimental design, analysis, and method validation. Since joining Skinvisible in 1998, he has been responsible for research and development of the Company's patented technology, related polymer delivery vehicles, product formulations and compositions. Dr. Roszell is a joint contributor to Skinvisible's initial technology patent and responsible for over 20 additional patents related to Invisicare technology. Prior to joining Skinvisible, Dr. Roszell was a research chemist in the Cancer Research Laboratory in the V.A. Hospital in Memphis, TN. and a research chemist in the Respiratory Carcinogenesis Program at the V.A. Hospital, Tampa, FL. Dr. Roszell has been the Director of Research and Development for Super Tech Products and Biochemical Industries. His invaluable chemical and scientific expertise are key factors in Skinvisible's innovative technological achievements.